Praliciguat

N/A

Report date: 2025/12/10 20:01:13
NME

Base Information

Drug NamePraliciguat
Drug Alias NameIW-1973
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSoluble guanylate cyclase stimulants
TargetsSoluble guanylate cyclase
Therapy Area/IndicationsDiabetes Mellitus, Type 2HypertensionHeart Failure, Diastolic +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesIronwood Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAkebia Therapeutics Inc
Inactive CompaniesCyclerion Therapeutics Inc
Active IndicationsGlomerulosclerosis, Focal Segmental
Inactive IndicationsDiabetes Mellitus, Type 2HypertensionHeart Failure, Diastolic +[4] 

Other Information

ATC CodeN/A
Related LinksN/A